Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Acquisitions (2019 - 2025)

Historic Acquisitions for Marimed (MRMD) over the last 5 years, with Q1 2025 value amounting to -$231000.0.

  • Marimed's Acquisitions changed N/A to -$231000.0 in Q1 2025 from the same period last year, while for Sep 2025 it was -$231000.0, marking a year-over-year decrease of 10543.53%. This contributed to the annual value of $4.2 million for FY2024, which is 4228.32% up from last year.
  • As of Q1 2025, Marimed's Acquisitions stood at -$231000.0.
  • Marimed's 5-year Acquisitions high stood at $12.7 million for Q2 2022, and its period low was -$231000.0 during Q1 2025.
  • In the last 4 years, Marimed's Acquisitions had a median value of $1.5 million in 2022 and averaged $3.3 million.
  • As far as peak fluctuations go, Marimed's Acquisitions plummeted by 10006.28% in 2023, and later surged by 5322500.0% in 2024.
  • Marimed's Acquisitions (Quarter) stood at $101000.0 in 2022, then crashed by 107.92% to -$8000.0 in 2023, then skyrocketed by 53225.0% to $4.2 million in 2024, then crashed by 105.44% to -$231000.0 in 2025.
  • Its last three reported values are -$231000.0 in Q1 2025, $4.2 million for Q2 2024, and -$8000.0 during Q2 2023.